MMJ Stock Play to Watch Keep PROW on your radar!

You may unsubscribe http://visitor.constantcontact.com/do?p=un&m=001zlmo8L7C1gRGzwsZrc1Ycw%3D%3D&ch=c7d6d5b0-1b17-11e3-a664-d4ae528eaba9&ca=2f502a2e-f39d-4352-9d57-ef15b030ea06 if you no longer wish to receive our emails. ———————————————————— SNPK Show me the money! SNPK is our pick for Monday….and Tuesday, Wednesday, Thursday and Friday! It is already up about double since Thursday with 258,583,762 shares traded already. There is still a lot of room for SNPK to soar high. A gain for SNPK would easily take it into multi-dollar level territories. Or almost $10 … We are sure that everyone would be happy with even half of that or a quarter of that, but as you know they say we need to aim high in life! Those of you who did buy SNPK last week are already up a lot, and those of you who didn’t buy it yet are definitely considering placing an order first thing Monday morning. As quick note keep in mind you will need to have a brokerage account other than TDameritrade to buy SNPK. If you are still with TDameritrade you should close your account right now and open one with a good company like Etrade or Schwab. SNPK is a pick we believe is going “viral” as everyone is tweeting about it, posting on facebook, showing up on message boards, at discussions around everyone’s dinner table and the talk of the moment at the office! The markets are near all time highs, and we are in the middle of a bull run. Our new pick could benefit big from these perfect conditions! SNPK owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions. The company is in the final stages of negotiations to engage former All-Star NBA player and current NBA head coach as National Clotamin spokesperson. Clotamin is already available in 9 states, and was just picked up by an important wholesale distributor Dakota Drug Inc. Don’t miss out! And remember, you heard it here first! Disclosures: http://www.hotshotstocks.com are not registered investment advisers or broker/dealers. http://www.hotshotstocks.com makes no recommendation that the purchase of securities of companies profiled in this Web site is suitable or advisable for any person or that an investment such securities will be profitable. Profiles is a special advertising section presented by HotShotStocks.com. All material listed within http://www.hotshotstocks.com was based upon information supplied by the company or from other sources believed to be reliable. The information contained on http://www.hotshotstocks.com is not guaranteed to be accurate and should not considered to be all-inclusive. The companies discussed on http://www.hotshotstocks.com except for those companies that appear on the URL http://HotShotStocks.com have not approved the statements made herein. Any discussions and pages contain forward looking statements that involve risks and uncertainties. A company’s actual results could differ materially from those described in any forward – looking statements or announcements discussed on http://www.hotshotstocks.com. All material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. http://www.hotshotstocks.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst, or underwriter. Companies profiled at URL http://www.hotshotstocks.com are ineligiable for recommendations on URL http://www.hotshotstocks.com for 90 days following final disposition of any compenstation. “Fair Disclosure”. We have not been compensated. Disclaimers Neither HotShot Stocks Corp nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Hot Shot Stocks Corp, licensed by HotShot Stocks from Information Providers, or gathered by HotShot Stocks from publicly available sources. There may be delays, omissions, or inaccuracies in the Information. NEITHER HOTSHOT STOCKS CORP NOR THE INFORMATION POVIDERS SHALL HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF THE INFORMATION OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON THE INFORMATION OR “HOTSHOTSTOCKS.COM,” OR FOR INTERRUPTION OF ANY DATA, INFORMATION, OR ANY OTHER ASPECT OF “HOTSHOTSTOCKS.COM.” THE PAST PERFORMANCE OF A MUTUAL FUND, STOCK, OR INVESTMENT STRATEGY CANNOT GUARANTEE ITS FUTURE PERFORMANCE. NEITHER HOTSHOT STOCKS CORP. NOR ITS INFORMATION PROVIDERS MAKE ANY REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, SOFTWARE, PRODUCTS, OR SERVICES CONTAINED IN “HOTSHOTSTOCKS.COM” ALL SUCH INFORMATION, SOFTWARE, PRODUCTS, AND SERVICES ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND. If you have received this email in error, or you wish to no longer be on the HotShot Stocks mailing list, please click here, type in the active email address and the word UNSUBSCRIBE. SNPK Show me the money! SNPK is our pick for Monday….and Tuesday, Wednesday, Thursday and Friday! It is already up about double since Thursday with 258,583,762 shares traded already. There is still a lot of room for SNPK to soar high. A gain for SNPK would easily take it into multi-dollar level territories. Or almost $10 … We are sure that everyone would be happy with even half of that or a quarter of that, but as you know they say we need to aim high in life! Those of you who did buy SNPK last week are already up a lot, and those of you who didn’t buy it yet are definitely considering placing an order first thing Monday morning. As quick note keep in mind you will need to have a brokerage account other than TDameritrade to buy SNPK. If you are still with TDameritrade you should close your account right now and open one with a good company like Etrade or Schwab. SNPK is a pick we believe is going “viral” as everyone is tweeting about it, posting on facebook, showing up on message boards, at discussions around everyone’s dinner table and the talk of the moment at the office! The markets are near all time highs, and we are in the middle of a bull run. Our new pick could benefit big from these perfect conditions! SNPK owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions. The company is in the final stages of negotiations to engage former All-Star NBA player and current NBA head coach as National Clotamin spokesperson. Clotamin is already available in 9 states, and was just picked up by an important wholesale distributor Dakota Drug Inc. Don’t miss out! And remember, you heard it here first! Forward email http://ui.constantcontact.com/sa/fwtf.jsp?llr=uvfkj4aab&m=1100561585844&ea=editor%40hotshotstocks.com&a=1116466486134 This email was sent to editor@stock-shocks.com by editor@hotshotstocks.com. Update Profile/Email Address http://visitor.constantcontact.com/do?p=oo&m=001zlmo8L7C1gRGzwsZrc1Ycw%3D%3D&ch=c7d6d5b0-1b17-11e3-a664-d4ae528eaba9&ca=2f502a2e-f39d-4352-9d57-ef15b030ea06 Instant removal with SafeUnsubscribe(TM) http://visitor.constantcontact.com/do?p=un&m=001zlmo8L7C1gRGzwsZrc1Ycw%3D%3D&ch=c7d6d5b0-1b17-11e3-a664-d4ae528eaba9&ca=2f502a2e-f39d-4352-9d57-ef15b030ea06 Privacy Policy: http://ui.constantcontact.com/roving/CCPrivacyPolicy.jsp Online Marketing by Constant Contact(R) www.constantcontact.com Hotshot Stocks Corp | 260 S. Milwaukee Ave | Wheeling | IL | 60090

This entry was posted in Newletter and tagged . Bookmark the permalink.

Comments are closed.